Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's lead liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment... TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's lead liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.065 | -4.1935483871 | 1.55 | 1.76 | 1.44 | 547383 | 1.64215588 | CS |
| 4 | -0.565 | -27.5609756098 | 2.05 | 2.155 | 1.44 | 412906 | 1.76554483 | CS |
| 12 | -1.585 | -51.6286644951 | 3.07 | 3.21 | 1.44 | 384987 | 2.16692297 | CS |
| 26 | -3.585 | -70.7100591716 | 5.07 | 6.225 | 1.44 | 373089 | 3.16912946 | CS |
| 52 | -6.535 | -81.4837905237 | 8.02 | 9.69 | 1.44 | 308557 | 4.66005512 | CS |
| 156 | -1.595 | -51.7857142857 | 3.08 | 9.69 | 1.44 | 286158 | 4.04140982 | CS |
| 260 | -10.515 | -87.625 | 12 | 14.71 | 1.44 | 244696 | 4.22313944 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
